Peptides and regulation of calcium channels
View Patent ↗Calcium channels can be regulated by natural gamma proteins. Herein we disclose embodiments of compositions and methods, particularly involving short peptides which are capable of regulating calcium channel function. Certain short peptides which can inhibit calcium current have structural features from the first transmembrane domain of gamma6 such as a GxxxA motif and adjoining aliphatic residues. In embodiments the peptide compositions and methods are capable of selective efficacy for low voltage-activated calcium channels, such as LVA channel Cav3.1, versus high voltage-activated channels.
1. An isolated peptide consisting of a sequence of 8 to 14 amino acids, wherein the sequence contains a GX 3 X 4 X 4 G-like structural motif, and wherein the sequence comprises X 1 -X 2 -X 3 -X 4 -X 5 -X 6 -X 7 -X 8 (SEQ ID NO:11); wherein X 1 is L, I, V, or F; X 2 is G, A, S, or T; X 3 is L, I, V, A, or F; X 4 is L, I, V, A, F, or T; X 4 is L, I, V, A, or F; X 6 is G, A, or S; and each X 7 and X 8 independently is L, I, V, A, or F; wherein said isolated peptide is capable of inhibiting voltage dependent calcium current in a cell.
2. The peptide of claim 1 wherein X1 is L, V, or F; X2 is G; at least two of X3, X4, and X5 are L, V, or F; and X6 is A.
3. The peptide of claim 1 wherein if X2 is other than G, X6 is G or A.
4. The peptide of claim 1 wherein X2 is G; X6 is A; and four of X1, X3, X4, X5, X7, and X8 are L, V, or F.
5. The peptide of claim 1 wherein the sequence comprises SEQ ID NO: 1.
6. The peptide of claim 1 wherein the sequence comprises SEQ ID NO:2.
7. The peptide of claim 1 comprises SEQ ID NO: 3.
8. The peptide of claim 1 comprises SEQ ID NO:4.
9. The peptide of claim 1 comprises SEQ ID NO:5.
10. The peptide of claim 1 comprises SEQ ID NO:6.
11. The peptide of claim 1 comprises SEQ ID NO:7.
12. A method of regulating a calcium channel comprising contacting said calcium channel with the peptide of claim 1 .
13. The method of claim 12 wherein said calcium channel is a voltage dependent calcium channel.
14. The method of claim 12 wherein said calcium channel is a low voltage activated calcium channel.
15. The method of claim 12 wherein said calcium channel is a high voltage activated calcium channel.
16. The method of claim 14 wherein said calcium channel is a Cav3.1 channel.
17. The method of claim 12 wherein said regulating inhibits calcium current.
18. The method of claim 12 wherein said regulating is selective for a low voltage activated channel.
19. The method of claim 12 wherein said calcium channel is in a mammalian cell.
20. The method of claim 12 wherein said mammalian cell is a cell line, a cardiomyocyte, or a neuronal cell.
21. The method of claim 12 wherein said regulating is at least partially reversible.
22. A pharmaceutical composition comprising as an active ingredient an effective amount of the peptide according to claim 1 .
23. The pharmaceutical composition of claim 22 further comprising a pharmaceutically acceptable carrier.
24. The peptide of claim 1 wherein each of X3, X4, and X5 independently is an aliphatic amino acid.
25. The peptide of claim 1 wherein the peptide consists of 9, 10, 11, 12, 13, or 14 amino acids.
26. The peptide of claim 1 wherein the peptide consists of eight amino acids.
27. The peptide of claim 26 wherein the sequence consists of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, or SEQ ID NO:7.
28. The peptide of claim 26 wherein the sequence consists of SEQ ID NO:1.